NL-OMON27919暂停不适用
Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?
Academic Medical Center - Amsterdam0 个研究点目标入组 22 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 22
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Informed consent form signed;
- •2. Type 2 diabetes patients, accoring to WHO criteria;
排除标准
- •1. Established coronary heart disease;
- •2. Previous use of a thiazolidinedione.
研究者
相似试验
已完成
不适用
Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?Diabetes mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetes mellitusISRCTN52245496Academic Medical Centre (AMC) (The Netherlands)22
尚未招募
2 期
The effect of Rosiglitazone on negative symptoms in schizophreniaSchizophreniaIRCT20090117001556N159niversity of social welfare and rehabilitation sciences50
尚未招募
2 期
The effect of Rosiglitazone in the treatment of depressioIRCT20090117001556N152Tehran University of Medical Sciences50
终止
3 期
Glitazones and Endothelial Function (GATE)Diabetes MellitusNCT00203632University of Calgary40
已完成
不适用
A comparison of the effects of rosiglitazone on endothelial function and arterial stiffness in insulin resistant individuals and normal controlsCardiovascular: Endothelial function and arterial stiffnessCirculatory SystemEndothelial function and arterial stiffnessISRCTN50847630Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)36